clinical trial · NCT07200375
An Observational Study of Glofitamab in Chinese Adult Participants With 2L Diffuse Large B-Cell Lymphoma
Diffuse Large B-Cell LymphomaGlofitamab
brief summary
This study will investigate how well glofitamab-based therapy works and how safe it is in Chinese adult participants with relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL).
started
Sep 29, 2025
primary completion
Sep 29, 2029
completion
Sep 29, 2029
last updated
Jun 3, 2026
official title
Evaluating Effectiveness and Safety of Glofitamab Based Second-Line Therapy in Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Prospective, Observational, Multicenter, Cohort Study
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol